Vice President, General Manager France

Company: Deciphera Pharmaceuticals
Location: Paris
Posted on: February 24, 2021

Job Description:

Deciphera Pharmaceuticals is a commercial biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates in clinical studies, QINLOCK--is Deciphera's first FDA-approved drug, a switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK, an oral oncolytic, is also approved in Canada and Australia for the treatment of fourth-line GIST. --Deciphera (NASDAQ: DCPH) is a publicly traded company headquartered in Waltham, Massachusetts. Our state-of-the-art research facility is located in Lawrence, Kansas. We offer an outstanding culture and opportunity for personal and professional growth based on our "PATHS" Core Values: - Patients - places the importance of improving the lives of patients and their caregivers at the forefront of every day's work. - Accountability - for our performance and the way we work with coworkers and other stakeholders. - Transparency - in our intent and actions to both internal and external stakeholders. - Honesty and Integrity - fosters trust and strives to deliver on our and the company's promises. - Stewardship - values and uses wisely the resources and investments provided to the company. Our Science and Our Pipeline: Deciphera is developing novel small molecule drug candidates to improve the lives of cancer patients by addressing key mechanisms of tumor and drug resistance that limit the effectiveness of many cancer therapies. Our pipeline of drug candidates is designed to stop cancers from growing and spreading by inhibiting mutant forms or over expression of a family of enzymes called kinase. Enabled by our proprietary kinase switch control inhibitor drug discovery platform, we have developed kinase switch control inhibitors that interact at a molecular level in a way that is distinct from other kinase inhibitors and are designed to generate higher and more durable rates of response. We have developed a diverse pipeline of differentiated, wholly owned, orally administered, oncology drug candidates that includes, among others, our recently approved product, QINLOCK (ripretinib), a broad-spectrum KIT and PDGFRa kinase switch control inhibitor is approved for the treatment of fourth-line GIST. Our follow-on study of ripretinib, the INTRIGUE study, is a pivotal Phase 3 trial in second-line GIST. We also have two additional clinical-stage programs for drug candidates DCC-3014 and rebastinib, both immune-oncology (or immunokinase) inhibitors, targeting the kinases CSF1R and TIE2 respectively. Two research-stage programs are in the pipeline as well. Position Summary: The successful candidate will build and lead Deciphera's local presence in France, lead and execute local pricing and market access activities, and develop broader local plans for world-class launches and ongoing success. Reporting to the Senior Vice President & General Manager, International, this is a unique opportunity for a strong French market leader to develop something completely new and play a key role on the broader European Leadership Team. Key Responsibilities:

• Represent Deciphera in France. Uphold high professional standards at all times, with respect to the internal organization and externally.
• Create and drive a high-performing, dynamic culture by fostering innovation, customer-focus, personal accountability, business acumen and a commitment to success.
• Ensure adherence to all relevant legal, regulatory and compliance requirements, corporate policies and procedures, and drive this culture in the local organization.
• Recruit, hire, train and retain top talent.
• Build and execute launch plans for Deciphera's products in France, establishing ambitious revenue growth and profit targets, coupled to prudent cost management. Maximize the potential of Deciphera's life-changing portfolio.
• Identify, propose, develop and execute local pricing and market access (P&MA) strategies that are consistent with European P&MA strategy.
• Establish strong working relationships with external bodies (Payors, Policy Makers, Patient Associations, KOLs, etc.).
• Foster an environment of strong cross-functional collaboration, within the local organization, regionally and globally.
• Identify and champion business development opportunities. Anticipated Challenges:
  • As Deciphera is now building its European organization, this is an exceptional and highly visible opportunity for a dynamic General Manager to build a world class local organization and drive P&L performance. Pivotal Experience & Expertise:
    • The successful candidate should be a dynamic biopharmaceutical leader, who is able to build something amazing. This person will have proven abilities as a biopharma commercial leader in France, perhaps as a General Manager or a Business Unit Leader. S/he will have led successful product launches, driven revenue growth and have a strong reputation for excellent cross-functional collaboration. Specifically, s/he will possess the following:
      • Undergraduate degree required, MBA and/or post graduate preferred.
      • A broad, multicultural cultural awareness, ideally with some international experience.
      • Excellent written and oral communication skills, including strong formal presentation skills. Ability to manage up, across and down.
      • Strong commercial leadership experience in the biopharmaceutical industry, either as a General/Country Manager, a BU Lead, or a Sales and Marketing Lead within France.
      • A successful track record of overseeing product launches, within the Oncology or orphan drug arena.
      • A thorough understanding of the market access and reimbursement environment and processes in France, with direct experience interacting with local health authorities and success in executing access and reimbursement strategies.
      • An ability and appetite to build relationships rapidly with KOLs and other key external stakeholders.
      • Written and oral fluency in French and English; other foreign language knowledge preferred. Leadership Capabilities:
        • Executive presence. Strong leadership qualities with the ability to attract talent, drive high performance and create a collaborative culture, fostering open communication, constructive conflict and organizational flexibility.
        • A high degree of emotional intelligence, displaying candor and integrity at all times.
        • An entrepreneurial and innovative mindset. Ability to manage though complexity and ambiguity, while focusing on the end goal.
        • Self-sufficiency, energy and drive to take this opportunity and run with it, with exceptional communication, as well as a level of comfort at working in a high-growth, fast-paced matrix environment.
        • Ability to influence across the broader organization.
        • A natural tendency to drive business decisions from a patient-centric mindset.

Keywords: Deciphera Pharmaceuticals, Fort Smith , Vice President, General Manager France, Executive , Paris, Arkansas